PD 15 – Confronting AMR through Sustainable Antibiotic R&D, Equitable Access and Responsible Stewardship


25 Oct 2021

Time: October 25, 12:30pm – 2pm CET / 10:30am – 12pm UTC

Speakers:

Dr. Erin Duffy, Chief of Research & Development, CARB-X

Dr. Michael Lobritz, Antibiotics Early Development Head, Roche

Henry Skinner, CEO, AMR Action Fund

Subasree Srinivasan, Medical Director, GARDP

About:

To successfully tackle the challenge of AMR, we need to increase support of sustainable antibiotic R&D. However, it is also important that there is both equitable access to, and responsible stewardship of antibiotics, so that these life-saving drugs are available for all patients who need them, whilst being safeguarded for future generations.

This session will explore what initiatives are already underway to achieve this, the roles and responsibilities of different stakeholders, and what new mechanisms we may need.

Join the digital session

Meeting ID: 832 0295 5649


We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.